European Society of Gene & Cell Therapy (ESGCT) Annual Congress 2026
Explore how we’re accelerating what's next in advanced therapies and how we can serve as your strategic partner for mRNA and viral vector programs.
October 27–30, 2026 | Hamburg, Germany | Booth #E08
About ESGCT Annual Congress 2026
The European Society of Gene & Cell Therapy (ESGCT) is dedicated to advancing science and research through various scientific and educational initiatives. The ESGCT Annual Congress brings together experts, researchers, and professionals in gene and cell therapy, providing a platform for sharing the latest research, advancements, and innovations in the field.
Throughout the year, ESGCT organizes numerous activities for its members to share information, explore technological advancements, and foster collaboration. The ESGCT Annual Congress is by far the largest of these events, and it’s celebrating its 33rd year in 2026. Thermo Fisher Scientific is excited to travel to Hamburg to attend this year’s congress alongside our peers.
Event details
Date: October 27–30, 2026
Format: In-person
Location: CCH-Congress Center Hamburg
Booth number: #E08
Event website:
https://www.esgctcongress.com
Why Thermo Fisher Scientific?
Advanced therapies utilizing next-generation technologies such as mRNA and viral vectors are set to change the biopharmaceutical industry as we know it. As a leading CDMO and CRO partner, we’re excited to be at the forefront of innovation in this field, supporting our drug development partners through every phase of the journey to market—from early development through scale-up, manufacturing, and commercialization.
Through collaborative partnerships with biotechnology and pharmaceutical companies, we are helping accelerate what’s next in advanced therapies. By combining scientific expertise, trusted guidance, and proven execution, our end-to-end offerings help transform possibilities into products that help patients in need around the globe. We look forward to showcasing our capabilities at ESGCT 2026 in Hamburg, Germany.
You’re invited: Poster presentations
We’re excited to present three posters at ESGCT 2026, featuring work from our industry expert, Pouria Motevalian, Director of Process Development at Thermo Fisher Scientific.
- Poster #1: Economics of rAAV manufacturing and cost reduction strategies
- Poster #2: Scalable AAV upstream development from high-throughput systems to 2,000 L
- Poster #3: Scalable lentiviral vector manufacturing for ex vivo and in vivo gene therapy applications
Please join us at booth #E08 to learn more about these poster presentations and meet Pouria in person. We will also have other subject matter experts on-site for 1:1 meetings.
Let’s connect at ESGCT 2026
Schedule a meeting with Thermo Fisher Scientific at the ESGCT Annual Congress 2026 to explore our integrated CDMO and CRO offerings, including services and solutions for mRNA and viral vector advanced therapy programs.
We look forward to seeing you in Hamburg.
Stay connected to new discoveries, innovations, and expert scientific opinions.
Follow us on social media for the latest up-to-date event happenings.
We look forward to seeing you soon